The Uncharacterized Protein C1orf21 Homolog activators encompass a diverse array of chemical compounds that interface with cellular signaling cascades to amplify the protein's activity. Forskolin, through the elevation of intracellular cAMP, could catalyze the activation of protein kinase A (PKA), which, in turn, might phosphorylate and thus enhance the activity of Uncharacterized Protein C1orf21 Homolog if it is PKA-responsive. IBMX, by inhibiting phosphodiesterases and raising cAMP and cGMP levels, potentially amplifies PKA or PKG activity, which might phosphorylate and activate the Uncharacterized Protein C1orf21 Homolog. Similarly, PMA, as a PKC activator, might augment the protein's activity if it is a PKC substrate. Ionomycin, by raising intracellular calcium, might activate calcium-dependent pathways that Uncharacterized Protein C1orf21 Homolog is part of. Sildenafil operates through PDE5 inhibition, thereby increasing cGMP and potentially activating PKG, which might phosphorylate the protein. Epigallocatechin gallate (EGCG), through its action as a kinase inhibitor, could relieve negative regulation of Uncharacterized Protein C1orf21 Homolog, enhancing its activity.
Moreover, LY294002's inhibition of PI3K might alter downstream pathways to favor those involving Uncharacterized Protein C1orf21 Homolog, if PI3K signaling regulates it. U0126, by inhibiting MEK1/2, could shift signaling to pathways that may include Uncharacterized Protein C1orf21 Homolog. A23187, another calcium ionophore, could similarly enhance the protein's activity through calcium-dependent signaling. Zaprinast, like Sildenafil, might elevate cGMP levels and activate PKG pathways involving Uncharacterized Protein C1orf21 Homolog. Nicotinamide riboside could boost NAD+-dependent processes that enhance the activity of the protein if it interacts with NAD+-dependent enzymes. Lastly, Paclitaxel's stabilization of microtubules might influence pathways linked to the cytoskeletal dynamics that could involve Uncharacterized Protein C1orf21 Homolog, enhancing its activity through alterations in cellular architecture.
SEE ALSO...
| Product Name | CAS # | Catalog # | QUANTITY | Price | Citations | RATING |
|---|---|---|---|---|---|---|
IBMX | 28822-58-4 | sc-201188 sc-201188B sc-201188A | 200 mg 500 mg 1 g | $260.00 $350.00 $500.00 | 34 | |
IBMX is a nonspecific inhibitor of phosphodiesterases, which prevents the breakdown of cAMP and cGMP. By increasing these cyclic nucleotides, IBMX could potentiate the activation of PKA or PKG, potentially enhancing the activity of the Uncharacterized protein C1orf21 homolog if it has sites responsive to these kinases. | ||||||
Phorbol | 17673-25-5 | sc-253267 | 5 mg | $270.00 | 1 | |
PMA is an activator of Protein Kinase C (PKC). The activation of PKC has been implicated in various signaling pathways, including some that involve phosphorylation of proteins. If the Uncharacterized protein C1orf21 homolog is a substrate of PKC, PMA could enhance its activity. | ||||||
Ionomycin | 56092-82-1 | sc-3592 sc-3592A | 1 mg 5 mg | $78.00 $270.00 | 80 | |
Ionomycin is a calcium ionophore that increases intracellular calcium levels. Calcium signaling is crucial in various cellular processes, and if the Uncharacterized protein C1orf21 homolog is part of a calcium-dependent pathway, the increased calcium could enhance its activity. | ||||||
(−)-Epigallocatechin Gallate | 989-51-5 | sc-200802 sc-200802A sc-200802B sc-200802C sc-200802D sc-200802E | 10 mg 50 mg 100 mg 500 mg 1 g 10 g | $43.00 $73.00 $126.00 $243.00 $530.00 $1259.00 | 11 | |
EGCG is a polyphenol compound with various biological effects, including kinase inhibition. If the Uncharacterized protein C1orf21 homolog is negatively regulated by a kinase that EGCG inhibits, its activity could be enhanced. | ||||||
LY 294002 | 154447-36-6 | sc-201426 sc-201426A | 5 mg 25 mg | $123.00 $400.00 | 148 | |
LY294002 is a PI3K inhibitor. By blocking PI3K signaling, it may shift the balance of downstream signaling pathways, potentially enhancing those involving the Uncharacterized protein C1orf21 homolog if it is regulated by PI3K-dependent pathways. | ||||||
A23187 | 52665-69-7 | sc-3591 sc-3591B sc-3591A sc-3591C | 1 mg 5 mg 10 mg 25 mg | $55.00 $131.00 $203.00 $317.00 | 23 | |
A23187 is another calcium ionophore, similar to Ionomycin, and could enhance the activity of the Uncharacterized protein C1orf21 homolog through calcium-dependent signaling mechanisms if relevant. | ||||||
Zaprinast (M&B 22948) | 37762-06-4 | sc-201206 sc-201206A | 25 mg 100 mg | $105.00 $250.00 | 8 | |
Zaprinast inhibits PDE5 like Sildenafil, and thus could enhance the activity of the Uncharacterized protein C1orf21 homolog by increasing cGMP levels and activating cGMP-dependent protein kinases. | ||||||